Gainers
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) rose 23.7% to $3.18 in pre-market trading after jumping 10% on Monday. The company, last month, priced its IPO at $10 per unit.
Allbirds (NASDAQ:BIRD) reported quarterly losses of $(0.25) per share. This is a 92.31 percent decrease over losses of $(0.13) per share from the same period last year. The company reported $62.70 million in sales this
Allbirds Inc.’s (NASDAQ: BIRD) focus on sustainability gives it a “unique competitive moat,” according to BofA Securities.
The Allbirds Analyst: Lorraine Hutchinson initiated coverage with a Buy rating and a price target of $23.